Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation
出版年份 2016 全文链接
标题
Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation
作者
关键词
-
出版物
ACTA PHARMACOLOGICA SINICA
Volume 38, Issue 1, Pages 69-79
出版商
Springer Nature
发表日期
2016-10-24
DOI
10.1038/aps.2016.119
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effects of alisol B 23-acetate on ovarian cancer cells: G1 phase cell cycle arrest, apoptosis, migration and invasion inhibition
- (2016) Le-Le Zhang et al. PHYTOMEDICINE
- Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice
- (2015) Lu Gan et al. ACTA PHARMACOLOGICA SINICA
- Tissue-specific actions of FXR in metabolism and cancer
- (2015) Raffaella Maria Gadaleta et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway
- (2015) Claudia Filozof et al. DRUGS
- Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
- (2015) Stuart McPherson et al. JOURNAL OF HEPATOLOGY
- Current efforts and trends in the treatment of NASH
- (2015) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial
- (2015) Eleonora Scorletti et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis
- (2014) Yang Jiao et al. ACTA PHARMACOLOGICA SINICA
- Alisol B 23-acetate promotes liver regeneration in mice after partial hepatectomy via activating farnesoid X receptor
- (2014) Qiang Meng et al. BIOCHEMICAL PHARMACOLOGY
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- From NAFLD in clinical practice to answers from guidelines
- (2013) Fabio Nascimbeni et al. JOURNAL OF HEPATOLOGY
- Small heterodimer partner overexpression partially protects against liver tumor development in farnesoid X receptor knockout mice
- (2013) Guodong Li et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- A new triterpenoid from Alisma orientale and their antibacterial effect
- (2012) Hong-Guang Jin et al. ARCHIVES OF PHARMACAL RESEARCH
- Non-alcoholic steatohepatitis: A non-invasive diagnosis by analysis of exhaled breath
- (2012) Froukje J. Verdam et al. JOURNAL OF HEPATOLOGY
- Tissue-specific function of farnesoid X receptor in liver and intestine
- (2011) Yan Zhu et al. PHARMACOLOGICAL RESEARCH
- The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis
- (2009) B. Cariou DIABETES & METABOLISM
- Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
- (2009) Songwen Zhang et al. JOURNAL OF HEPATOLOGY
- Alisol B acetate induces apoptosis of SGC7901 cells via mitochondrial and phosphatidylinositol 3-kinases/Akt signaling pathways
- (2009) Yong-Hong Xu et al. WORLD JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now